VEGFA and Miyoshi myopathy: Matrigel VM assays were performed using the VEGFA high- and low-MM cell lines NCI-H28 and NCI-H226 respectively (1878 pg/mL vs. 109 pg/mL seeded at 2.0 × 105 cells/mL under normoxic conditions after 24 h), to observe potential differences in growth patterns depending on VEGFA status.